Learn more

SHANGHAI EPIPROBE BIOTECHNOLOGY CO LTD

Overview
  • Total Patents
    21
  • GoodIP Patent Rank
    79,862
About

SHANGHAI EPIPROBE BIOTECHNOLOGY CO LTD has a total of 21 patent applications. Its first patent ever was published in 2018. It filed its patents most often in China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology and organic fine chemistry are HANGZHOU ZC BIO SCI & TECH CO LTD, SUREXAM BIOLOG TECHNOLOGY CO LTD and JINAN ADICON CLINICAL LABORATORIES INC.

Patent filings in countries

World map showing SHANGHAI EPIPROBE BIOTECHNOLOGY CO LTDs patent filings in countries

Patent filings per year

Chart showing SHANGHAI EPIPROBE BIOTECHNOLOGY CO LTDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Li Zhenyan 21
#2 Luo Huaibing 16
#3 Dong Shihua 1
#4 Xu Peng 1

Latest patents

Publication Filing date Title
CN111979303A Nucleic acid detection kit, method and application thereof
CN111020034A Novel marker for diagnosing tumor and application thereof
WO2020135861A1 Methylation modification-based tumor marker stamp-ep4
CN110229913A Broad spectrum activity marker and its application based on methylation level detection tumour
CN110055330A Tumor marker STAMP-EP9 and its application based on methylation modification
CN109971860A Tumor marker STAMP-EP8 and its application based on methylation modification
CN109988844A Tumor marker STAMP-EP7 and its application based on methylation modification
CN109456968A Tumor marker STAMP-EP5 based on methylation modification
CN109652541A Tumor marker STAMP-EP6 based on methylation modification
CN109554476A Tumor marker STAMP-EP3 based on methylation modification
CN109554451A Method that is a kind of while carrying out explanations of genomic DNA polymorphism and DNA methylation assay
CN108866192A Tumor marker STAMP-EP1 based on methylation modification
CN108866191A Tumor marker STAMP-EP2 based on methylation modification